Skip to main content
. 2023 Apr 1;29(5):249–255. doi: 10.5761/atcs.oa.22-00242

Table 2. Demographic and preoperative data of patients.

Preoperative variables Death group (n = 23) Survival group (n = 169) t/χ2 P value
Age (years)  60.9 ± 10.5  52.3 ± 11.2 3.494 0.001
Female, n (%)  6 (26.1)  47 (27.8) 0.030 0.862
Body mass index (kg/m2) 25.1 ± 1.4 24.6 ± 1.5 1.539 0.125
Hypertension, n (%) 15 (65.2) 123 (72.8) 0.573 0.449
Diabetes n (%) 2 (8.7) 12 (7.1) 0.076 0.783
Chronic obstructive pulmonary disease, n (%) 2 (8.7) 14 (8.3) 0.004 0.947
Smoking, n (%)  7 (30.4)  41 (24.3) 0.412 0.521
CAD history, n (%)  3 (13.0)  9 (5.3) 2.058 0.151
Marfan’s syndrome, n (%) 1 (4.3)  5 (3.0) 0.129 0.719
Cardiac surgery history, n (%) 1 (4.3)  9 (5.3) 0.039 0.843
LVEF (%) 54.3 ± 3.0 55.4 ± 2.8 1.615 0.108
Preoperative serum creatinine (μmol/L) 103.2 ± 19.0  97.2 ± 13.5 1.888 0.060
Pericardial tamponade/shock, n (%)  4 (17.4) 10 (5.9) 3.943 0.047
MPS, n (%) 10 (43.5)  39 (23.1) 4.433 0.035
Emergency operation, n (%) 21 (91.3) 159 (94.1) 0.267 0.606

CAD: coronary artery disease; LVEF: left ventricular ejection fraction; MPS: malperfusion syndrome